What type of study is this?

This is a Quasi-experimental study.

September 5, 2025Pakistan Armed Forces Medical JournalOpen Access

Evaluation of Changes in Macular Thickness following Nepafenac Ophthalmic Drops in Chronic Diabetes

View Full Paper

Ask AI

Bookmark

Authors

MJMuhammad JahanzaibUniversity of Karachi FHFakhar Humayun SNSaad Naseer

Discussion

Member takes

Implication

Quasi-experimental study shows Nepafenac significantly improves visual acuity and reduces macular thickness in patients with diabetic retinopathy, highlighting its potential as a treatment option.

Key Points

Nepafenac ophthalmic drops significantly reduced mean foveal thickness from 472.14 microns to 253.69 microns after six months.
Visual acuity improved from 0.79 to 0.62 log units, with a p-value of less than 0.001, indicating high statistical significance.
Participants received 0.1% Nepafenac eyedrops twice daily for six months, illustrating a well-defined treatment regimen.
Study findings support the clinical effectiveness of Nepafenac in managing macular edema for diabetic retinopathy patients.

Cite This Study

Jahanzaib et al. (2025) studied this question.

synapsesocial.com/papers/68bb46b56d6d5674bccfe6dd https://doi.org/10.51253/pafmj.v75i4.11847

View Full Paper

Ask AI

Bookmark

Implication

Quasi-experimental study shows Nepafenac significantly improves visual acuity and reduces macular thickness in patients with diabetic retinopathy, highlighting its potential as a treatment option.

Evaluation of Changes in Macular Thickness following Nepafenac Ophthalmic Drops in Chronic Diabetes

Discussion

Member takes

Implication

Key Points

Cite This Study

Evaluation of Changes in Macular Thickness following Nepafenac Ophthalmic Drops in Chronic Diabetes

Discussion

Member takes

Implication

Key Points

Cite This Study

Also Consider

Also Consider